ATTO (Attovia Therapeutics) Accumulated Depreciation: $-1.34 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATTO Attovia Therapeutics Inc ATTO
8 GF Score
Price $20.70
View Full Analysis

What is Attovia Therapeutics Accumulated Depreciation?

Attovia Therapeutics ATTO -6.94% 8 Accumulated Depreciation is $-1.34 Mil as of Mar. 2026. GuruFocus rates ATTO with a GF Score™ of 8/100.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Attovia Therapeutics's quarterly accumulated depreciation increased from Mar. 2025 ($0.00 Mil) to Dec. 2025 ($-1.10 Mil) and increased from Dec. 2025 ($-1.10 Mil) to Mar. 2026 ($-1.34 Mil).

Attovia Therapeutics's annual accumulated depreciation declined from . 20 ($0.00 Mil) to Dec. 2024 ($-0.30 Mil) but then increased from Dec. 2024 ($-0.30 Mil) to Dec. 2025 ($-1.10 Mil).

Attovia Therapeutics Accumulated Depreciation Related Terms

Attovia Therapeutics Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Attovia Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attovia Therapeutics Accumulated Depreciation Chart

Attovia Therapeutics Annual Data
Trend Dec24 Dec25
Accumulated Depreciation
-0.30 -1.10

Attovia Therapeutics Quarterly Data
Dec24 Mar25 Dec25 Mar26
Accumulated Depreciation -0.30 0.00 -1.10 -1.34
ATTO
8GF Score
Attovia Therapeutics Inc ATTO
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Attovia Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-1.34 Mil mean?
Attovia Therapeutics (ATTO) has a Accumulated Depreciation of $-1.34 Mil as of Mar. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Attovia Therapeutics and its competitors.
Is Attovia Therapeutics' Accumulated Depreciation too high?
Attovia Therapeutics' current Accumulated Depreciation is $-1.34 Mil. Overall, Attovia Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Attovia Therapeutics' Accumulated Depreciation compare to ?
Attovia Therapeutics' Accumulated Depreciation of $-1.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Attovia Therapeutics and its competitors. Attovia Therapeutics's current Accumulated Depreciation is $-1.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attovia Therapeutics stock overvalued right now?
Attovia Therapeutics (ATTO) has a current Accumulated Depreciation of $-1.34 Mil. The current Accumulated Depreciation is $-1.34 Mil. Attovia Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Attovia Therapeutics (ATTO), the current Accumulated Depreciation is $-1.34 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Attovia Therapeutics Business Description

Comparable Companies
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
8GF Score

Get the complete analysis for ATTO

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.70
Price